TA
BMY icon

TMD & Associates’s Bristol-Myers Squibb BMY Stock Holding History

TMD & Associates’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-7,647
Closed -$526K – 31
2015
Q4 		$526K Buy
+7,647
New +$505K 0.48% 29

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

TMD & Associates's BMY Position: Q1 2016 in Review

TMD & Associates sold out of Bristol-Myers Squibb (BMY) in Q1 2016, closing a stake of 7,647 shares — an estimated $526K sold.

TMD & Associates first reported a position in BMY in Q4 2015 and held it in 1 quarter. The position peaked at $526K in Q4 2015. 1,523 funds tracked by Wall St. Rank hold BMY as of Q1 2016.

  • TMD & Associates reported no remaining Bristol-Myers Squibb position as of Q1 2016 after selling out during the quarter.
  • TMD & Associates sold 7,647 Bristol-Myers Squibb shares in Q1 2016, an estimated $526K.
  • TMD & Associates first reported a position in Bristol-Myers Squibb in Q4 2015 and held it in 1 quarter.
  • TMD & Associates's Bristol-Myers Squibb position peaked at $526K in Q4 2015.
  • 1,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2016.

Based on TMD & Associates's 13F filing for Q1 2016, filed 16 May 2016.